Acylated phenylethanoid glycosides, echinacoside and acteoside from Cistanche tubulosa, improve glucose tolerance in mice
Acylated phenylethanoid glycosides, echinacoside and acteoside from Cistanche tubulosa, improve glucose tolerance in mice
复制标题
DOI:
10.1007/s11418-014-0837-9
复制
发表时间:
2014-07-01
影响因子:
3.3
通讯作者:
Muraoka, Osamu
中科院分区:
文献类型:
--
作者:
Morikawa, Toshio;Ninomiya, Kiyofumi;Muraoka, Osamu
Acylated phenylethanoid glycosides, echinacoside (1) and acteoside (2), principal constituents in stems of Cistanche tubulosa (Orobanchaceae), inhibited the increase in postprandial blood glucose levels in starch-loaded mice at doses of 250-500 mg/kg p.o. These compounds (1 and 2) also significantly improved glucose tolerance in starch-loaded mice after 2 weeks of continuous administration at doses of 125 and/or 250 mg/kg/day p.o. without producing significant changes in body weight or food intake. In addition, several constituents from C. tubulosa, including 1 (IC50 = 3.1 mu M), 2 (1.2 mu M), isoacteoside (3, 4.6 mu M), 2'-acetylacteoside (4, 0.071 mu M), tubulosides A (5, 8.8 mu M) and B (9, 4.0 mu M), syringalide A 3-O-alpha-l-rhamnopyranoside (10, 1.1 mu M), campneoside I (13, 0.53 mu M), and kankanoside J(1) (14, 9.3 mu M), demonstrated potent rat lens aldose reductase inhibitory activity. In particular, the potency of compound 4 was similar to that of epalrestat (0.072 mu M), a clinical aldose reductase inhibitor.